Quantification of T cell clonality in human T cell leukaemia virus type-1 carriers can detect the development of adult T cell leukaemia early
My diagnosis was PMBCL; stage IV
Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up
All TP53 mutations are NOT equal: Does the "deleterious effect" of the TP53 mutation affect the outcome of Myelodysplastic Syndrome?
Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes
Konstantinos Liapis & Ioannis Kotsianidis, on behalf of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes.